WebSofosbuvir/velpatasvir, sold under the brand name Epclusa among others, is a fixed-dose combination medication for the treatment of hepatitis C in adults. [2] [3] [4] [5] It combines sofosbuvir and velpatasvir. [2] [3] [4] It is more than 90% effective for hepatitis C genotypes one through six. [2] WebMay 5, 2024 · The drug interactions described are based on studies conducted with either EPCLUSA, the components of EPCLUSA (sofosbuvir and velpatasvir) as individual …
Sofosbuvir/velpatasvir - Wikipedia
WebSMC No. 1271/17. Sofosbuvir with velpatasvir (Epclusa®) for the treatment of chronic hepatitis C virus (HCV) infection in adults [with genotype 2, 5 or 6 chronic HCV infection, … Web2 days ago · Liverpool HEP Interactions Looking for interactions with COVID-19 therapies, including Paxlovid? Click here for covid19-druginteractions.org If a drug is not listed below it cannot automatically be assumed it is safe to coadminister HEP Drugs A-Z Indication Trade Selected HEP Drugs will be displayed here. Co-medications A-Z Class options other than nfl sunday ticket
EPCLUSA (sofosbuvir/velpatasvir)
WebInteractions Enter a drug name and sofosbuvir/velpatasvir All Interactions Sort By: Contraindicated (0) Serious - Use Alternative (44) amiodarone apalutamide armodafinil … WebThe most common adverse reactions (≥10%, all grades) with EPCLUSA in adults and pediatric patients 6 years of age and older were headache and fatigue; and when used … WebEpclusa disease interactions There are 3 disease interactions with Epclusa (sofosbuvir / velpatasvir) which include: immunosuppression hepatic impairment renal impairment Report options Share by QR Code Email this report to a friend, doctor, or patient Ask questions, … options other than mammogram